SEQUANA MEDICAL NV (SEQUA.BR) Fundamental Analysis & Valuation

EBR:SEQUA • BE0974340722

0.539 EUR
+0.01 (+2.67%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This SEQUA.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

SEQUA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. SEQUA has a bad profitability rating. Also its financial health evaluation is rather negative. SEQUA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. SEQUA.BR Profitability Analysis

1.1 Basic Checks

  • In the past year SEQUA has reported negative net income.
  • In the past year SEQUA has reported a negative cash flow from operations.
  • SEQUA had negative earnings in each of the past 5 years.
  • SEQUA had a negative operating cash flow in each of the past 5 years.
SEQUA.BR Yearly Net Income VS EBIT VS OCF VS FCFSEQUA.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • SEQUA has a worse Return On Assets (-355.86%) than 95.24% of its industry peers.
Industry RankSector Rank
ROA -355.86%
ROE N/A
ROIC N/A
ROA(3y)-296.55%
ROA(5y)-236.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SEQUA.BR Yearly ROA, ROE, ROICSEQUA.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for SEQUA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SEQUA.BR Yearly Profit, Operating, Gross MarginsSEQUA.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. SEQUA.BR Health Analysis

2.1 Basic Checks

  • SEQUA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SEQUA has been increased compared to 1 year ago.
  • The number of shares outstanding for SEQUA has been increased compared to 5 years ago.
  • SEQUA has a worse debt/assets ratio than last year.
SEQUA.BR Yearly Shares OutstandingSEQUA.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SEQUA.BR Yearly Total Debt VS Total AssetsSEQUA.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • SEQUA has an Altman-Z score of -31.39. This is a bad value and indicates that SEQUA is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -31.39, SEQUA is not doing good in the industry: 92.06% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -31.39
ROIC/WACCN/A
WACC5.81%
SEQUA.BR Yearly LT Debt VS Equity VS FCFSEQUA.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M -40M

2.3 Liquidity

  • A Current Ratio of 0.20 indicates that SEQUA may have some problems paying its short term obligations.
  • The Current ratio of SEQUA (0.20) is worse than 95.24% of its industry peers.
  • A Quick Ratio of 0.16 indicates that SEQUA may have some problems paying its short term obligations.
  • The Quick ratio of SEQUA (0.16) is worse than 93.65% of its industry peers.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.16
SEQUA.BR Yearly Current Assets VS Current LiabilitesSEQUA.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SEQUA.BR Growth Analysis

3.1 Past

  • The earnings per share for SEQUA have decreased strongly by -32.31% in the last year.
  • SEQUA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
  • SEQUA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -35.84% yearly.
EPS 1Y (TTM)-32.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.99%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-34.21%
Revenue growth 5Y-35.84%
Sales Q2Q%-100%

3.2 Future

  • SEQUA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.42% yearly.
  • Based on estimates for the next years, SEQUA will show a very strong growth in Revenue. The Revenue will grow by 462.98% on average per year.
EPS Next Y81.63%
EPS Next 2Y32.86%
EPS Next 3Y26.42%
EPS Next 5YN/A
Revenue Next Year782.35%
Revenue Next 2Y689.05%
Revenue Next 3Y462.98%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SEQUA.BR Yearly Revenue VS EstimatesSEQUA.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M
SEQUA.BR Yearly EPS VS EstimatesSEQUA.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. SEQUA.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • SEQUA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SEQUA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SEQUA.BR Price Earnings VS Forward Price EarningsSEQUA.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SEQUA.BR Per share dataSEQUA.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

  • SEQUA's earnings are expected to grow with 26.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.86%
EPS Next 3Y26.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SEQUA.BR Dividend Analysis

5.1 Amount

  • No dividends for SEQUA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SEQUA.BR Fundamentals: All Metrics, Ratios and Statistics

SEQUANA MEDICAL NV

EBR:SEQUA (3/6/2026, 7:00:00 PM)

0.539

+0.01 (+2.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)09-04
Earnings (Next)03-25
Inst Owners32.97%
Inst Owner ChangeN/A
Ins Owners4.4%
Ins Owner ChangeN/A
Market Cap40.17M
Revenue(TTM)N/A
Net Income(TTM)-51.85M
Analysts84
Price Target2.79 (417.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-21.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)47.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)12.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.24
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0
BVpS-0.53
TBVpS-0.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -355.86%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-296.55%
ROA(5y)-236.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.31%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.2
Quick Ratio 0.16
Altman-Z -31.39
F-Score2
WACC5.81%
ROIC/WACCN/A
Cap/Depr(3y)113.39%
Cap/Depr(5y)92.99%
Cap/Sales(3y)87.76%
Cap/Sales(5y)73.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.99%
EPS Next Y81.63%
EPS Next 2Y32.86%
EPS Next 3Y26.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3Y-34.21%
Revenue growth 5Y-35.84%
Sales Q2Q%-100%
Revenue Next Year782.35%
Revenue Next 2Y689.05%
Revenue Next 3Y462.98%
Revenue Next 5YN/A
EBIT growth 1Y23.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-16.37%
EBIT Next 3Y-3.53%
EBIT Next 5YN/A
FCF growth 1Y41.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.9%
OCF growth 3YN/A
OCF growth 5YN/A

SEQUANA MEDICAL NV / SEQUA.BR FAQ

What is the fundamental rating for SEQUA stock?

ChartMill assigns a fundamental rating of 1 / 10 to SEQUA.BR.


What is the valuation status for SEQUA stock?

ChartMill assigns a valuation rating of 1 / 10 to SEQUANA MEDICAL NV (SEQUA.BR). This can be considered as Overvalued.


How profitable is SEQUANA MEDICAL NV (SEQUA.BR) stock?

SEQUANA MEDICAL NV (SEQUA.BR) has a profitability rating of 0 / 10.